HER2 testing in metastatic colorectal cancer: ready for prime time?
Publication
, Journal Article
Hurwitz, HI
Published in: Clin Adv Hematol Oncol
April 2016
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
April 2016
Volume
14
Issue
4
Start / End Page
235 / 237
Location
United States
Related Subject Headings
- Treatment Outcome
- Receptor, erbB-2
- Receptor, ErbB-2
- Prognosis
- Oncology & Carcinogenesis
- Mutation
- Molecular Targeted Therapy
- Immunohistochemistry
- Humans
- Genetic Variation
Citation
APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H. I. (2016). HER2 testing in metastatic colorectal cancer: ready for prime time? Clin Adv Hematol Oncol, 14(4), 235–237.
Hurwitz, Herbert I. “HER2 testing in metastatic colorectal cancer: ready for prime time?” Clin Adv Hematol Oncol 14, no. 4 (April 2016): 235–37.
Hurwitz HI. HER2 testing in metastatic colorectal cancer: ready for prime time? Clin Adv Hematol Oncol. 2016 Apr;14(4):235–7.
Hurwitz, Herbert I. “HER2 testing in metastatic colorectal cancer: ready for prime time?” Clin Adv Hematol Oncol, vol. 14, no. 4, Apr. 2016, pp. 235–37.
Hurwitz HI. HER2 testing in metastatic colorectal cancer: ready for prime time? Clin Adv Hematol Oncol. 2016 Apr;14(4):235–237.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
April 2016
Volume
14
Issue
4
Start / End Page
235 / 237
Location
United States
Related Subject Headings
- Treatment Outcome
- Receptor, erbB-2
- Receptor, ErbB-2
- Prognosis
- Oncology & Carcinogenesis
- Mutation
- Molecular Targeted Therapy
- Immunohistochemistry
- Humans
- Genetic Variation